安必平收盘下跌4.28%，滚动市盈率1291.34倍，总市值28.89亿元

Core Viewpoint - Anbiping's stock price closed at 30.88 yuan, down 4.28%, with a rolling PE ratio of 1291.34 times, significantly higher than the industry average [1] Company Summary - Anbiping's main business includes tumor screening and diagnostic reagents, automation equipment, and auxiliary diagnostic AI software [1] - The latest performance report for Q1 2025 shows a revenue of 72.54 million yuan, a year-on-year decrease of 28.51%, and a net loss of approximately 11.06 million yuan, a year-on-year decline of 238.49%, with a gross profit margin of 61.97% [1] Industry Summary - The average PE ratio for the medical device industry is 48.98 times, with a median of 36.16 times, placing Anbiping at the 121st position in the industry ranking [2] - The total market capitalization of Anbiping is 2.889 billion yuan [2] - As of Q1 2025, there are 7 institutions holding shares in Anbiping, with a total holding of 26.54 million shares valued at 949.7 million yuan [1]